Grade 2 CRS occurred after the second CAR-T infusion, lasting 7 days; Grade 3 myelosuppression led to lenalidomide discontinuation; IL-6 peak level: 119.8 pg/mL, transient elevation of inflammatory cytokines. This evidence concerns the gene IL6 and congenital rubella syndrome.